PsiOxus Therapeutics Ltd.
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of protein therapeutics and synthetic payloads within solid tumors. At PsiOxus, we are committed to unlocking the potential of immuno-oncology in solid tumors to improve survival rates for individuals battling cancer. Our team of business leaders, clinicians, research scientists, and other specialists are dedicated to developing new cancer treatments targeting unmet needs. Making a difference every day, with the goal of helping patients, is at the heart of what we do. PsiOxus aims to lead the world in tumor re-engineering, delivering medicines of significant benefit to patients with cancer.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About Us
This approach can drive sustained reprogramming of the tumor microenvironment in both primary and metastatic sites. Our approach overcomes the central challenge of cancers’ resistance to current treatments and enables the development of a new paradigm for cancer cure in the future.
We have a rapidly expanding and advancing pipeline of novel monotherapy and combination product candidates that have shown a consistent safety profile and increasing evidence of efficacy surrogates such as biomarkers in studies to date.
Our Vision
We aim to lead the world in tumor re-engineering, delivering medicines of value to patients with cancer.
Our Strategy
PsiOxus is a clinical stage oncology company pioneering systemic immune oncology products that drives sustained reprogramming of the tumor microenvironment to overcome the central challenge of resistance to therapy.
Our Values
We choose to fight cancer
alongside all of those patients who did not choose to be in that fight.
We choose to make a difference
because innovation and science can push the boundaries of what is possible.
We choose to work with honesty and integrity
because we recognise the important responsibilities that we have.
We choose to respect each other and our partners
because by working together we can achieve so much more than by working alone.